glp 1 breastfeeding GLP-1s and — Bridges Lactation Safety of GLP-1 Medications During
Description
Frontiers in Pharmacology, 16 , Article 1539411
As summarized in the article by Drucker et al., it is a class of drugs that has potential benefits in the treatment of type 2 diabetes
The FDA has approved several agents specifically for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity
DPP-4 inhibitors do not have significant effects on GI motility or appetite that are observed with more efficacious (DPP-4 resistant) GLP-1 agonists
Many can define a prescription-only medicine, but struggle to correctly identify specific products
[DOI] [PubMed] [Google Scholar] 6.Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al
